BioSpace News Archive

Electrocardiograph (ECG) Market Research Report 2022-2030 | Share, Global Trends, Key Players, Growth Analysis to 2030

The global Electrocardiograph market size was estimated at USD 9.2 billion in 2021 and is expected to surpass around USD 21.7 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 10% during the forecast period 2022 to 2030.

September 23, 2022
·
9 min read
Hemodialysis And Peritoneal Dialysis Market Size to Hit USD 156.63 Bn by 2030

According to Nova one advisor, the global Hemodialysis and Peritoneal Dialysis market was valued at USD 88.20 billion in 2021 and it is expected to hit around USD 156.63 billion by 2030 with a CAGR of 6.65% during the forecast period 2022 to 2030.

September 23, 2022
·
11 min read
Business

InfuSystem Appoints R. Rimmy Malhotra to the Board of Directors

InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”) announced today the appointment of R. Rimmy Malhotra, a new independent director to InfuSystem’s Board of Directors, effective September 20, 2022.

September 23, 2022
·
4 min read
Biotech Bay

Surge Raises $2.6M, Secures Exclusive Licensing Agreement with Stanford to Make Surgeries Safer

Biotech and medical AI innovator Surge announced a $2.6 million round co-led by HCVC, a global early-stage fund dedicated to high-potential technology startups, and Boutique Venture Partners, a leading fund based in the Silicon Valley.

September 23, 2022
·
5 min read
Biotech Bay

Adverum Biotechnologies to Participate in the Jefferies Cell and Genetic Medicine Summit

Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that Peter Soparkar, chief operating officer of Adverum Biotechnologies, will present at the Jefferies Cell and Genetic Medicine Summit on September 29, 2022, at 9:30 a.m. ET.

September 23, 2022
·
1 min read
Biotech Beach

Palisade Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 23, 2022

Palisade Bio, Inc. announced that it had made equity grants to two new employees under its 2021 Inducement Plan.

September 23, 2022
·
3 min read
Pharm Country

PDS Biotech Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 23, 2022

PDS Biotechnology Corporation announced PDS Biotech granted nonstatutory stock options to Amber King, PDS Biotech’s Clinical Trial Assistant, to purchase 5,000 shares of PDS Biotech common stock.

September 23, 2022
·
6 min read
Business

Concord Medical Reports Financial Results for the First Half of 2022

Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM) today announced its unaudited consolidated financial results for the six months ended June 30, 2022[1].

September 23, 2022
·
16 min read
Pharm Country

Disarming the immune system’s lethal lung response

Caryl Boies professor of cancer research at Cold Spring Harbor Laboratory (CSHL), and his team have found a drug candidate that can prevent lethal lung inflammation in mice by inhibiting a protein called PTP1B.

September 23, 2022
·
2 min read